New Product: Zenpep™ (pancrelipase) Delayed-Release Capsules

Zenpep available for exocrine pancreatic insufficiency (EPI)

December 23, 2009

Eurand Pharmaceuticals announced that FDA-approved Zenpep (pancrelipase delayed-release capsules) is available for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis or other conditions.

Zenpep approved for exocrine pancreatic insufficiency (EPI)

August 31, 2009

The FDA has approved Zenpep (pancrelipase delayed-release capsules, from Eurand N.V.), a pancreatic enzyme product (PEP) for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions.

Creon delayed-release capsules available for exocrine pancreatic insufficiency

July 07, 2009

Solvay Pharmaceuticals has made available Creon (pancrelipase) delayed-release capsules, a "zero-overfill" pancreatic enzyme product that targets 100% of the lipase amount indicated on the product labeling.

Creon delayed-release capsules approved for exocrine pancreatic insufficiency due to cystic fibrosis

May 01, 2009

Creon (pancrelipase, from Solvay Pharmaceuticals) delayed-release capsules, a pancreatic enzyme product (PEP), has received FDA approval for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF) or other conditions under the new guidelines for this class of drugs.

Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)

March 12, 2010

The FDA has approved a five-day dosing regimen for Dacogen (decitabine for injection, from Eisai) to treat patients with myelodysplastic syndromes (MDS).

KU-ZYME

Gastrointestinal Tract > Digestive and biliary disorders

Lipase 1200 Units, amylase 15000 Units, protease 15000 Units; caps.

LACTAID DROPS

Gastrointestinal Tract > Digestive and biliary disorders

Lactase 1250Units; per 5 drops; liq.

PANCRECARB MS-8

Gastrointestinal Tract > Digestive and biliary disorders

Lipase 8000Units, amylase 40000Units, protease 45000Units; e-c microspheres (buffered) in delayed-release caps.

VIOKASE 8

Gastrointestinal Tract > Digestive and biliary disorders

Lipase 8000Units, protease 30000Units, amylase 30000Units; tabs.

VIOKASE POWDER

Gastrointestinal Tract > Digestive and biliary disorders

Lipase 16800Units, protease 70000Units, amylase 70000Units; per 0.7g pwd.

Gastrointestinal Tract > Digestive and biliary disorders

BILE ACIDS: Bile acids (eg, ursodiol) stimulate bile flow, inhibit cholesterol synthesis, promote cholesterol excretion, and are involved in the ...
more »

New Product: SAPHRIS^® (asenapine) Sublingual Tablets

March 09, 2010

CerefolinNAC^® (L-methylfolate [Metafolin], methylcobalamin, N-acetylcysteine) Caplets: A Novel Approach to Early Memory Loss

January 27, 2010

New Product: Zenpep™ (pancrelipase) Delayed-Release Capsules

January 13, 2010

INVEGA^® SUSTENNA™ (paliperidone palmitate) Extended-Release Injectable Suspension for Acute and Maintenance Treatment of Schizophrenia

January 05, 2010

FORTEO^® (teriparatide [rDNA origin] injection) for Use in Glucocorticoid-Induced Osteoporosis

December 17, 2009

Recommended Adult Immunization Schedule

March 02, 2010

This schedule indicates the recommended age groups and medical indications for routine administration of currently licensed vaccines for persons 19 years and older.

Antiemetic Medications

February 05, 2010

A list of drugs used for the treatment of nausea. The chart includes the formulations, strengths, and usual doses for each antiemetic drug product.

Catch-Up Immunization Schedule for Children

February 02, 2010

A catch-up immunization schedule for children 4 months to 18 years of age. The tables show minimum intervals between doses for children who have delayed immunizations.

Recommended Immunization Schedule for Ages 0 to 18 Years

January 21, 2010

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children through age 18 years.

Mood Disorder Treatments

January 12, 2010

Mood disorder treatments for bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others.